Influence of the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-1) trial on the use of thrombolytics in Germany. ALKK Study Group. Arbeitsgemeinschaft der Leitenden Kardiologischen Krankenhausärtze.
作者信息
Zahn R, Rustige J, Koch A, Schiele R, Burczyk U, Schuster S, Harmjanz D, Boppert D, Gottwik M, Neuhaus K L, Senges J
机构信息
Herzzentrum Ludwigshafen, Kardiologie, Germany.
出版信息
Am J Cardiol. 1997 Nov 15;80(10):1339-43. doi: 10.1016/s0002-9149(97)00677-2.
PMID:9388110
Abstract
Our results show significant and independent influence of the GUSTO-1 trial on the use of recombinant tissue plasminogen activator in acute myocardial infarction in Germany. This influence started soon after the publication of the trial and was not restricted to subgroups who benefitted most from recombinant tissue plasminogen activator.
摘要
Zotero 插件